Your Lab Report, Decoded: What Diuretic Patients Need to Know About Flagged Blood Work

There is a particular kind of anxiety that arrives with a patient portal notification: your lab results are ready. You open the report, scan the columns, and notice a cluster of values printed in bold or marked with a small 'H' or 'L' beside them. Without context, these flags can feel alarming—especially if no one has explained that some of these shifts are expected, even predictable, consequences of the medication you are taking.

Diuretics are among the most metabolically active medications in common use. They do not simply remove fluid; they alter the balance of electrolytes, affect kidney filtration markers, and in some cases influence blood sugar. Understanding what your lab results are actually measuring—and how your medication interacts with each marker—transforms you from a passive recipient of data into an informed participant in your own care.

How to Read a Basic Metabolic Panel

Most patients on diuretic therapy will have a basic metabolic panel (BMP) or comprehensive metabolic panel (CMP) ordered periodically. These tests measure a cluster of values that together paint a picture of kidney function, electrolyte balance, and glucose metabolism. The markers most likely to be affected by diuretic therapy include sodium, potassium, chloride, carbon dioxide (bicarbonate), creatinine, blood urea nitrogen (BUN), and glucose.

Reference ranges printed on your lab report represent population-level norms. A value slightly outside that range is not automatically cause for alarm—context matters enormously. What your provider is looking for is the direction and magnitude of change over time, not a single data point in isolation.

Sodium: When 'Low' Doesn't Always Mean Dangerous

Normal serum sodium typically falls between 136 and 145 milliequivalents per liter (mEq/L). Diuretics—particularly thiazides—are among the most common causes of hyponatremia, or low sodium, in outpatient medicine.

The mechanism is straightforward: by increasing urinary excretion of sodium-containing fluid, diuretics can deplete sodium stores if intake does not compensate. Mild hyponatremia (sodium between 130 and 135 mEq/L) may produce no symptoms at all. Moderate to severe cases can cause fatigue, headache, confusion, or nausea.

If your sodium reads slightly below the reference range, your provider may ask about your fluid intake, review whether you are drinking excessive amounts of plain water (which dilutes sodium further), or consider adjusting your dose. A mildly low sodium on a single panel is not the same as a crisis—but it is a signal worth tracking.

Potassium: The Number Most Patients Have Heard About

Of all the electrolyte shifts associated with diuretic therapy, potassium loss receives the most attention—and for good reason. Normal serum potassium ranges from approximately 3.5 to 5.0 mEq/L. Loop diuretics (such as furosemide) and thiazide diuretics promote potassium excretion, making hypokalemia (low potassium) a common finding in patients on these medications.

Symptoms of low potassium include muscle weakness, cramps, fatigue, and in more severe cases, cardiac arrhythmias. If your potassium reads below 3.5, your provider may recommend dietary modifications, a potassium supplement, or a switch to or addition of a potassium-sparing diuretic such as spironolactone.

Conversely, if you are already taking a potassium-sparing agent, your report may flag an elevated potassium (hyperkalemia). A value above 5.0 mEq/L warrants attention, as high potassium can also affect heart rhythm. The key question to bring to your provider: 'Is my potassium trend moving in a safe direction, and does my current supplementation or dietary intake need adjustment?'

Creatinine and BUN: What Your Kidneys Are Trying to Tell You

Creatinine is a waste product filtered by the kidneys; elevated levels suggest reduced kidney filtration efficiency. Normal creatinine is generally 0.7 to 1.3 mg/dL in adults, though this varies by age, sex, and muscle mass. Blood urea nitrogen (BUN) is another kidney filtration marker, with a normal range of approximately 7 to 20 mg/dL.

Diuretics can cause a mild, transient rise in both creatinine and BUN, particularly during the early weeks of therapy or following a dose increase. This occurs because reducing circulating fluid volume can temporarily decrease blood flow to the kidneys—a phenomenon called pre-renal azotemia. In most cases, this stabilizes as the body adjusts.

However, a persistent or significant rise in creatinine—particularly if accompanied by reduced urine output or swelling—warrants prompt evaluation. Patients with pre-existing kidney disease require especially close monitoring, as their margin for fluid and filtration shifts is narrower.

When reviewing your results, note whether your creatinine has changed from your previous panel. A single elevated value is less informative than a trend. Ask your provider: 'Is this increase within expected range for my medication, or does it suggest my kidneys need additional support?'

Glucose: An Underappreciated Connection

Many patients are surprised to learn that diuretics—particularly thiazides—can influence blood glucose levels. The mechanism involves effects on insulin secretion and peripheral insulin sensitivity. For most patients without diabetes, this effect is modest and clinically insignificant. For patients with diabetes or prediabetes, however, even a small upward shift in fasting glucose warrants monitoring.

If your fasting glucose appears flagged as elevated (above 100 mg/dL for fasting, or above 126 mg/dL on two separate occasions), this does not necessarily mean your diuretic has caused diabetes—but it does mean the conversation with your provider should include a review of your glucose trend over time and whether your current medication regimen remains the best fit.

Chloride and Bicarbonate: The Supporting Cast

Chloride and carbon dioxide (reported as bicarbonate on most panels) reflect your body's acid-base balance. Diuretics can shift this balance in either direction depending on the drug class. Loop diuretics can cause metabolic alkalosis (elevated bicarbonate), while carbonic anhydrase inhibitors can cause metabolic acidosis (low bicarbonate). These shifts are typically mild and self-correcting, but significant deviations warrant clinical review.

If you see either of these values flagged and you are uncertain why, simply note it and ask your provider whether the shift is expected given your specific medication.

Turning Confusion Into Conversation

The most productive thing a diuretic patient can do before a follow-up appointment is review their most recent lab report and identify which values are flagged, in which direction, and how they compare to the previous panel. A simple written list of questions—'My potassium dropped from 3.8 to 3.3 since my last test. Should I be concerned?'—gives your provider something concrete to address rather than requiring you to reconstruct the conversation from memory.

At LasixUN Health, we work to ensure that patients receiving prescriptions through our platform have access to the contextual information they need to understand their treatment. A lab result is not a verdict—it is a data point in an ongoing dialogue between you and your care team.